基本信息
views: 89
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Mansoor Khan has served FDA for over 11 years as the Director of Product Quality Research and a Senior Biomedical Research Scientist (SBRS) at CDER, where he helped develop regulatory policies for reviews and compliance, and led chemistry and manufacturing control (cmc) review and research teams on drug delivery systems, product stability, biotech products, and biopharmaceutics. As a formulations expert, Dr. Khan served as a FDA representative to EMA (European Medical Agency), WHO, USP, NIH, DoD, DARPA, NASA, and Bill and Melinda Gates Foundation. He also served as the science policy advisor to CDER Center Director where he helped resolve complex issues of drug reviews and compliance with science. He has also led the chemistry review team that approved the first 3D printed tablets in August 2015. Dr. Khan is an AAPS Fellow. Khan has published over 300 peer-reviewed manuscripts in product formulations and evaluation. In this presentation, Khan will talk about the opportunities and ability of TAMU researchers to convert academic discoveries into commercial products.
Research Interests
Papers共 385 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pharmaceutical Researchno. 1 (2024): 129-139
AAPS PharmSciTechno. 1 (2024): 20-20
AAPS PharmSciTechno. 1 (2024): 19-19
Pharmaceutical Researchno. 5 (2024): 1-14
Advanced clinical pharmacy - research, development and practical applicationspp.137-172, (2023)
Cited1Views0Bibtex
1
0
Perspective of Recent Advances in Medical Research Vol. 3pp.34-43, (2023)
Load More
Author Statistics
#Papers: 385
#Citation: 15039
H-Index: 60
G-Index: 105
Sociability: 7
Diversity: 3
Activity: 47
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn